These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7982463)

  • 1. Beta-funaltrexamine blockade of opioid-induced inhibition of somatostatin secretion from rat stomach.
    McIntosh C; Yago V; Kwok YN
    Eur J Pharmacol; 1994 Jul; 259(3):331-4. PubMed ID: 7982463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the opioid receptor type mediating inhibition of rat gastric somatostatin secretion.
    McIntosh CH; Jia X; Kowk YN
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G922-7. PubMed ID: 1979718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of mu-opioid receptors on SH-SY5Y cells using naloxonazine and beta-funaltrexamine.
    Elliott J; Smart D; Lambert DG; Traynor JR
    Eur J Pharmacol; 1994 Aug; 268(3):447-50. PubMed ID: 7805771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for mu opioid receptor mediation of enkephalin-induced electroencephalographic seizures.
    Tortella FC; Robles L; Mosberg HI
    J Pharmacol Exp Ther; 1987 Feb; 240(2):571-7. PubMed ID: 3027318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric effects of mu-, delta- and kappa-opioid receptor agonists on brainstem unitary responses in the neonatal rat.
    Yuan CS
    Eur J Pharmacol; 1996 Oct; 314(1-2):27-32. PubMed ID: 8957215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enkephalinergic control of somatostatin secretion from the perfused rat stomach.
    McIntosh CH; Kwok YN; Mordhorst T; Nishimura E; Pederson RA; Brown JC
    Can J Physiol Pharmacol; 1983 Jul; 61(7):657-63. PubMed ID: 6137272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the mu-opioid receptors on SH-SY5Y cells using beta-funaltrexamine (beta-FNA) and naloxonazine.
    Elliott J; Smart D; Traynor JR; Lambert DG
    Biochem Soc Trans; 1993 Nov; 21(4):469S. PubMed ID: 8132037
    [No Abstract]   [Full Text] [Related]  

  • 8. Selective antagonism by naloxonazine of antinociception by Tyr-D-Arg-Phe-beta-Ala, a novel dermorphin analogue with high affinity at mu-opioid receptors.
    Sakurada S; Takeda S; Sato T; Hayashi T; Yuki M; Kutsuwa M; Tan-No K; Sakurada C; Kisara K; Sakurada T
    Eur J Pharmacol; 2000 Apr; 395(2):107-12. PubMed ID: 10794815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of opioid receptors on smooth muscle cells from guinea pig stomach.
    Zhang L; Gu ZF; Pradhan T; Jensen RT; Maton PN
    Am J Physiol; 1992 Mar; 262(3 Pt 1):G461-9. PubMed ID: 1312793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of opioid receptor antagonists on vasodilator nerve actions in the perfused rat mesentery.
    Li YJ; Duckles SP
    Eur J Pharmacol; 1991 Nov; 204(3):323-8. PubMed ID: 1685449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
    Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
    Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential regulation of adenylyl cyclase activity by mu and delta opioids in rat caudate putamen and nucleus accumbens.
    Izenwasser S; Búzás B; Cox BM
    J Pharmacol Exp Ther; 1993 Oct; 267(1):145-52. PubMed ID: 7901389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mu-opioid receptor modulates GABAA receptor-mediated currents in isolated spinal dorsal horn neurons.
    Wang RA; Randić M
    Neurosci Lett; 1994 Oct; 180(2):109-13. PubMed ID: 7700561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that nor-binaltorphimine can function as an antagonist at multiple opioid receptor subtypes.
    Spanagel R; Almeida OF; Shippenberg TS
    Eur J Pharmacol; 1994 Oct; 264(2):157-62. PubMed ID: 7851478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of endomorphin on substantia gelatinosa neurons in rat spinal cord slices.
    Wu SY; Ohtubo Y; Brailoiu GC; Dun NJ
    Br J Pharmacol; 2003 Nov; 140(6):1088-96. PubMed ID: 14530213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of specific opioid agonists and antagonists to delineate the vagally mediated antinociceptive and cardiovascular effects of intravenous morphine.
    Randich A; Robertson JD; Willingham T
    Brain Res; 1993 Feb; 603(2):186-200. PubMed ID: 8096421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
    Mjanger E; Yaksh TL
    J Pharmacol Exp Ther; 1991 Aug; 258(2):544-50. PubMed ID: 1650833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of delta receptor mediation of supraspinal opioid analgesia by in vivo protection against the beta-funaltrexamine antagonist effect.
    Sánchez-Blázquez P; Garzón J
    Eur J Pharmacol; 1989 Jan; 159(1):9-23. PubMed ID: 2565240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of central mechanisms involved in gastric mucosal integrity].
    Gyires K; Zádori Z
    Neuropsychopharmacol Hung; 2008 Jun; 10(3):121-5. PubMed ID: 18956615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opiate suppression of LH secretion involves central receptors different from those mediating opiate effects on prolactin secretion.
    Pfeiffer DG; Pfeiffer A; Almeida OF; Herz A
    J Endocrinol; 1987 Sep; 114(3):469-76. PubMed ID: 2822829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.